Abstracts Archive - Page 1785 of 2425 - ACR Meeting Abstracts

Abstract Number: 1438 • 2015 ACR/ARHP Annual Meeting
Oral Potassium (K+) Reduces Pain in RA: A Randomized Active Control Study of Diet Based K+ Intervention
Toktam Kainifard¹, Manjit Saluja², Anuradha Venugopalan³, Raju Rane⁴ and Arvind Chopra⁵, ¹Rheumatology, PhD fellow, Pune, India, ²Clinical care, Center for Rheumatic Diseases, Pune, India, ³Rheumatology, R & D, Lab, Center for Rheumatic Diseases, Pune, India, ⁴Pathology, Pathologist, Pune, India, ⁵Rheumatology, Centre for Rheumatic Diseases, Pune 411001, India
Background/Purpose: National Health and Nutrition Survey III (1988-94,USA) data showed a low K+ body status in RA. Further information is scanty. K+ is critical to…
Abstract Number: 1439 • 2015 ACR/ARHP Annual Meeting
Reducing Gastric Ulcers in Patients with a History of Gastrointestinal (GI) Ulcers Who Require Long-Term High-Dose Non-Steroidal Anti-Inflammatory Drug (NSAID) Therapy
John Fort¹, Robert J. Holt², Jeffrey D. Kent³ and Alfonso Bello⁴, ¹POZEN Inc., Chapel Hill, NC, ²College of Pharmacy, University of Illinois-Chicago, Vernon Hill, IL, ³Horizon Pharma USA, Inc., Deerfield, IL, ⁴Illinois Bone & Joint Inst, Glenview, IL
Background/Purpose: Patients ≥65 taking naproxen with previous GI symptoms have a 29% annual incidence of significant upper gastrointestinal events.(1) Those patients who are older, with…
Abstract Number: 1440 • 2015 ACR/ARHP Annual Meeting
Outcomes and Cost-Effectiveness of Shoulder Injections with Sonographic Needle Guidance
Timothy Moore¹, Wilmer Sibbitt Jr.¹, Cole Paffett², Dan Tandberg³, Arthur Bankhurst⁴, Roderick Fields⁵ and Suzanne Emil¹, ¹Rheumatology, University of New Mexico, Albuquerque, NM, ²School of Medicine, Univeristy of New Mexico, Albuquerque, NM, ³University of New Mexico, Albuquerque, NM, ⁴Rheum/ MSC 105550, University of NM Med Ctr, Albuquerque, NM, ⁵Rheumatology, University of New Mexico, Albquerque, NM
Background/Purpose: Sonographic needle guidance (USG) of musculoskeletal injections has improved outcomes of intraarticular (IA) injections, but is associated with increased procedural costs. This practical randomized…
Abstract Number: 1441 • 2015 ACR/ARHP Annual Meeting
Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials
Ninna Karsbæk Senftleber^1,2, Sabrina Mai Nielsen^3,4, Jens Rikardt Andersen⁴, Henning Bliddal⁵, Simon Tarp³, Lotte Lauritzen⁴, Daniel E. Furst⁶, Maria E. Suarez-Almazor⁷, Anne Lyddiatt⁸ and Robin Christensen⁵, ¹Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiksberg and Bispebjerg, Denmark, ²Department of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark, ³Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, ⁴Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark, ⁵The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, ⁶Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, ⁷General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, ⁸Musculoskeletal Group, Cochrane Collaboration, Ottawa, ON, Canada
Background/Purpose: Marine oil supplements (MOS) are suggested to have anti-inflammatory properties, but there is no consensus regarding the efficacy of MOS in the management of…
Abstract Number: 1442 • 2015 ACR/ARHP Annual Meeting
Descriptive Characteristics of Patients Prescribed Opioids for the Treatment of Chronic Pain
Jenna Goesling¹, Stephanie Moser², Afton L. Hassett³, Chad Brummett¹ and Natalie Gulau¹, ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ³Anesthesiology, University of Michigan Medical School, Ann Arbor, MI
Background/Purpose: Opioids remain the cornerstone of acute pain therapy. However, there is little empirical evidence supporting the use of long-term opioid therapy for chronic pain.…
Abstract Number: 1443 • 2015 ACR/ARHP Annual Meeting
A Multiple Ascending-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirogabalin in Healthy Elderly Subjects
Karen Brown¹, Yoshihiro Kumagae¹, Shoichi Ohwada², Vance Warren¹, Hamim Zahir¹ and Victor Dishy¹, ¹Daiichi Sankyo Pharma Development, Edison, NJ, ²Daiichi Sankyo Co., Ltd., Tokyo, Japan
Background/Purpose: Mirogabalin (DS-5565) is a preferentially selective a2d-1 ligand intended for treatment of pain associated with fibromyalgia and neuropathic pain. We evaluated the safety, tolerability,…
Abstract Number: 1444 • 2015 ACR/ARHP Annual Meeting
Validation of a Revised Version of the Michigan Body Map
Chad Brummett¹, Rishi Bakshi², Daniel Leung¹, Jennifer Zollars³, Jenna Goesling¹, Stephanie Moser⁴, David A. Williams⁵ and Afton L. Hassett⁶, ¹Anesthesiology, University of Michigan, Ann Arbor, MI, ²Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, ³Anesthesiology, University of Michigan Health System, Ann Arbor, MI, ⁴Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ⁵Anesthseiology, University of Michigan, Ann Arbor, MI, ⁶Anesthesiology, University of Michigan Medical School, Ann Arbor, MI
Title: Validation of a Revised Version of the Michigan Body MapBackground/Purpose: One of the hallmark features of fibromyalgia and other centralized pain states is widespread…
Abstract Number: 1445 • 2015 ACR/ARHP Annual Meeting
Physicians’ Perspectives on the Diagnosis and Treatment of Chronic Nonbacterial Osteomyelitis
Yongdong Zhao¹, Fatma Dedeoglu², Polly J. Ferguson³, Sivia Lapidus⁴, Ronald Laxer⁵, Suzanne C. Li⁶ and for the CARRA SVRD subcommittee, ¹Pediatric Rheumatology, Seattle Children's Hospital, Seattle, WA, ²Rheumatology, Boston Children's Hospital, Boston, MA, ³Dept of Pediatrics--Rheum, University of Iowa, Iowa City, IA, ⁴Pediatric Rheumatology, Goryeb Children's Hospital, Morristown, NJ, ⁵Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ⁶Pediatrics, Joseph M Sanzari Children’s Hospital, Hackensack University Medical Center, Hackensack, NJ
Background/Purpose: Chronic nonbacterial osteomyelitis (CNO), also known as chronic recurrent multifocal osteomyelitis (CRMO), is an autoinflammatory bone disease of unknown cause that can result in…
Abstract Number: 1446 • 2015 ACR/ARHP Annual Meeting
Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry
Daniel J Lovell¹, N Ruperto², S Spalding³, JA Dare⁴, R Cimaz⁵, V Stanevica⁶, RK Vehe⁷, N Tzaribachev⁸, G Horneff⁹, M Trachana¹⁰, TA Simon¹¹, HI Brunner¹² and A Martini², ¹Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Istituto G. Gaslini Pediatria II Reumatologia, Genova, Italy, ³Cleveland Clinic, Cleveland, OH, ⁴University of Arkansas Medical Center, Little Rock, AR, ⁵Azienda Ospedaliero-Universitaria Meyer, Florence, Italy, ⁶Riga Stradins University, Riga, Latvia, ⁷University of Minnesota, Minneapolis, MN, ⁸Pediatric Rheumatology, Bad Bramstedt, Germany, ⁹Asklepios Klinik Zentrum für Allgemeine Paediatrie und Neonatologie, Sankt Augustin, Germany, ¹⁰Hippokration General Hospital, Thessaloniki, Greece, ¹¹Bristol-Myers Squibb, Hopewell, NJ, ¹²Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Background/Purpose: Abatacept (ABA) is a widely approved and used biologic in children with juvenile idiopathic arthritis (JIA). The purpose of this study was to describe…
Abstract Number: 1447 • 2015 ACR/ARHP Annual Meeting
Positive Power Doppler Signal Increases the Risk of Clinical Flare of Patients with Juvenile Idiopathic Arthritis in Clinical Remission: A Prospective Study
Vanessa B Miotto e Silva¹, Octavio Peracchi², Claudio A. Len³, Sônia A.V. Mitraud⁴, Rita NV Furtado⁵, Jamil Natour⁶ and Maria Teresa Terreri⁷, ¹Pediatrics, Universidade Federal de São Paulo / UNIFESP, São Paulo, Brazil, ²Pediatric Rheumatology, Assistent Doctor, Sao Paulo, Brazil, ³Pediatrics, Universidade Federal de São Paulo, São Paulo,, Brazil, ⁴Radiology and Diagnostic Imaging, Escola Paulista de Medicina/ Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, Brazil, ⁵Medicine, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, ⁶Rheumatology Division, Federal University of Sao Paulo, Sao Paulo, Brazil, ⁷Pediatrics, Universidade Federal de Sao Paulo, São Paulo, Brazil
Background/Purpose: Prior ultrasound (US) studies in patients with juvenile idiopathic arthritis (JIA) in clinical remission have demonstrated the presence of subclinical synovitis. However, the significance…
Abstract Number: 1448 • 2015 ACR/ARHP Annual Meeting
Progressive Pseudorheumatoid Arthropathy of Childhood (PPAC) – a Single Center Case Series
Renate Haefner, Boris Huegle and Johannes Peter Haas, German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany
Background/Purpose: Progressive pseudorheumatoid arthropathy of childhood (PPAC, OMIM #208230) is a bone dysplasia caused by mutations in the WISP3 gene. Due to its presentation…
Abstract Number: 1449 • 2015 ACR/ARHP Annual Meeting
The Effect of IL-1 Receptor Antagonist Anakinra (Kineret®) on Measures of Central Nervous System Inflammation and Headaches in Pediatric Patients with Severe Cryopyrin-Associated Periodic Syndromes
Hans Olivecrona¹, Raphaela Goldbach-Mansky², Torbjörn Kullenberg¹ and Mika Leinonen³, ¹Swedish Orphan Biovitrum, Stockholm, Sweden, ²Translational Autoinflammatory Diseases Section, NIAMS, NIH, Bethesda, MD, ³4Pharma AB, Stockholm, Sweden
Background/Purpose: Cryopyrin-Associated Periodic Syndromes (CAPS) include a group of rare inherited autoinflammatory diseases consisting of Familial Cold Autoinflammatory Syndrome (FCAS), Muckle-Wells Syndrome and the most…
Abstract Number: 1450 • 2015 ACR/ARHP Annual Meeting
Clostridium Difficile Infection-Associated Reactive Arthritis in a Pediatric Cohort
Daniel B. Horton^1,2,3, Brian L. Strom^1,3, Mary E. Putt³, Carlos D. Rose², David D. Sherry⁴ and Julia S. Sammons⁵, ¹Rutgers Biomedical and Health Sciences, New Brunswick, NJ, ²Pediatrics, Nemours A.I. duPont Hospital for Children, Division of Pediatric Rheumatology, Thomas Jefferson University, Wilmington, DE, ³Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, ⁴Pediatrics, Children's Hospital of Philadelphia, Division of Pediatric Rheumatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, ⁵Pediatrics, Infection Prevention and Control, Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
Background/Purpose: The incidence of Clostridium difficile infection (CDI) has increased among children, and CDI is associated with significant morbidity and mortality. Cases of C. difficile…
Abstract Number: 1451 • 2015 ACR/ARHP Annual Meeting
Neurologic Findings and Serial Neuroimaging in Patients with Linear Scleroderma En Coup De Sabre (ECDS) and Parry-Romberg Syndrome (PRS)
Rebecca Prengler¹, Stephanie Morris¹, Soe Mar¹, Andrew J. White² and Susan Bayliss¹, ¹St. Louis Children's Hospital, St. Louis, MO, ²Washington University, St. Louis Children's Hospital, St. Louis, MO
Background/Purpose: To describe the evolution of neurologic symptoms and neuroradiologic findings in patients with ECDS and PRS. Methods: The medical records database at St. Louis…
Abstract Number: 1452 • 2015 ACR/ARHP Annual Meeting
Pauciimmune and Immune Mediated Pulmonary Capillaritis in Children
Jennifer Soares^1,2, Gail Deutsch^2,3, BreAnna Kinghorn² and Anne M. Stevens⁴, ¹Pediatric Pulmonary and Sleep Division, Seattle Children's Hospital, Seattle, WA, ²School of Medicine, University of Washington, Seattle, WA, ³Pathology, Seattle Children's Hospital, Seattle, WA, ⁴Seattle Children's Res Inst, Seattle Children's Hospital, Seattle, WA
Background/Purpose: Immune mediated and pauciimmune pulmonary capillaritis are rare causes of diffuse alveolar hemorrhage and associated childhood diffuse lung disease. As such ideal therapies and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].